A Study to Investigate the Possible Causes of Secondary Effects During Use of Peripheral Midline Type Catheter in Patients Hospitalized in Different Care Settings
NCT ID: NCT04391205
Last Updated: 2020-05-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
211 participants
OBSERVATIONAL
2017-04-26
2019-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
"Follow-up of Midlines Placed Outside the Intensive Care Unit: What Side Effects? An Observational Study"
NCT04131088
Evaluation of the Efficacy and Safety of Midline Venous Catheters
NCT05835531
Comparison of Two Peripheral Inserted Intravenous Catheters
NCT04140916
Prospective Evaluation of Complications of MidLine Catheters in the ICU
NCT05412108
Venous Thrombosis After Removal of Central Venous Catheter
NCT06349291
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects submitted to Midline type venous catheter insertion
Exclusion Criteria
* Be hospitalized for less than a week
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
A.O.U. Città della Salute e della Scienza
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dott.ssa RENATA MARINELLO
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Renata Marinello, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
OAU Città della Salute e della Scienza di Torino, Turin, Italy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Marinello Renata
Turin, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0041902
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.